Advertisement
Loading...

PeptiDream Inc.

PPTDFPNK
Healthcare
Biotechnology
$7.02
$0.00(0.00%)
U.S. Market is Open • 15:38

PeptiDream Inc. Fundamental Analysis

PeptiDream Inc. (PPTDF) shows weak financial fundamentals with a PE ratio of -57.47, profit margin of -13.11%, and ROE of -4.81%. The company generates $19.0B in annual revenue with weak year-over-year growth of -60.32%.

Key Strengths

Cash Position2834.74%
PEG Ratio0.00
Current Ratio4.06

Areas of Concern

ROE-4.81%
Operating Margin-18.40%
We analyze PPTDF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -99.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-99.6/100

We analyze PPTDF's fundamental strength across five key dimensions:

Efficiency Score

Weak

PPTDF struggles to generate sufficient returns from assets.

ROA > 10%
-3.34%

Valuation Score

Excellent

PPTDF trades at attractive valuation levels.

PE < 25
-57.47
PEG Ratio < 2
0.00

Growth Score

Weak

PPTDF faces weak or negative growth trends.

Revenue Growth > 5%
-60.32%
EPS Growth > 10%
-1.25%

Financial Health Score

Excellent

PPTDF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.33
Current Ratio > 1
4.06

Profitability Score

Weak

PPTDF struggles to sustain strong margins.

ROE > 15%
-481.21%
Net Margin ≥ 15%
-13.11%
Positive Free Cash Flow
No

Key Financial Metrics

Is PPTDF Expensive or Cheap?

P/E Ratio

PPTDF trades at -57.47 times earnings. This suggests potential undervaluation.

-57.47

PEG Ratio

When adjusting for growth, PPTDF's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values PeptiDream Inc. at 2.88 times its book value. This may indicate undervaluation.

2.88

EV/EBITDA

Enterprise value stands at -81.77 times EBITDA. This is generally considered low.

-81.77

How Well Does PPTDF Make Money?

Net Profit Margin

For every $100 in sales, PeptiDream Inc. keeps $-13.11 as profit after all expenses.

-13.11%

Operating Margin

Core operations generate -18.40 in profit for every $100 in revenue, before interest and taxes.

-18.40%

ROE

Management delivers $-4.81 in profit for every $100 of shareholder equity.

-4.81%

ROA

PeptiDream Inc. generates $-3.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.34%

Following the Money - Real Cash Generation

Operating Cash Flow

PeptiDream Inc. generates limited operating cash flow of $-3.39B, signaling weaker underlying cash strength.

$-3.39B

Free Cash Flow

PeptiDream Inc. generates weak or negative free cash flow of $-4.40B, restricting financial flexibility.

$-4.40B

FCF Per Share

Each share generates $-34.21 in free cash annually.

$-34.21

FCF Yield

PPTDF converts -3.08% of its market value into free cash.

-3.08%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-57.47

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.001

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.49

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.05

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.05

vs 25 benchmark

How PPTDF Stacks Against Its Sector Peers

MetricPPTDF ValueSector AveragePerformance
P/E Ratio-57.4728.65 Better (Cheaper)
ROE-4.81%795.00% Weak
Net Margin-13.11%-49787.00% (disorted) Weak
Debt/Equity0.330.40 Neutral
Current Ratio4.063.73 Strong Liquidity
ROA-3.34%-20255.00% (disorted) Weak

PPTDF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews PeptiDream Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

54.15%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-181.91%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-844.68%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ